Daraxonrasib wins FDA approval for advanced pancreatic cancer The Food and Drug Administration on Wednesday, August 26, approved a groundbreaking new drug for advanced pancreatic cancer that offers double survival time against one of the deadliest forms of cancer. The one-day pill, .. .



